nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—prostate cancer—testicular cancer	0.601	1	CtDrD
Ethinyl Estradiol—AOX1—Methotrexate—testicular cancer	0.037	0.121	CbGbCtD
Ethinyl Estradiol—ABCB11—Vinblastine—testicular cancer	0.0357	0.116	CbGbCtD
Ethinyl Estradiol—CYP2B6—Ifosfamide—testicular cancer	0.0225	0.0733	CbGbCtD
Ethinyl Estradiol—ABCB11—Doxorubicin—testicular cancer	0.0219	0.0715	CbGbCtD
Ethinyl Estradiol—ABCC2—Carboplatin—testicular cancer	0.0201	0.0656	CbGbCtD
Ethinyl Estradiol—ABCC2—Vinblastine—testicular cancer	0.0188	0.0612	CbGbCtD
Ethinyl Estradiol—ABCC2—Cisplatin—testicular cancer	0.0172	0.0561	CbGbCtD
Ethinyl Estradiol—CYP2C8—Ifosfamide—testicular cancer	0.017	0.0555	CbGbCtD
Ethinyl Estradiol—ABCC2—Etoposide—testicular cancer	0.0169	0.0551	CbGbCtD
Ethinyl Estradiol—ABCC2—Doxorubicin—testicular cancer	0.0115	0.0376	CbGbCtD
Ethinyl Estradiol—ABCC2—Methotrexate—testicular cancer	0.0112	0.0364	CbGbCtD
Ethinyl Estradiol—CYP2B6—Cisplatin—testicular cancer	0.0109	0.0357	CbGbCtD
Ethinyl Estradiol—ABCB1—Dactinomycin—testicular cancer	0.00976	0.0318	CbGbCtD
Ethinyl Estradiol—ESR2—seminiferous tubule of testis—testicular cancer	0.00852	0.227	CbGeAlD
Ethinyl Estradiol—SHBG—seminiferous tubule of testis—testicular cancer	0.00828	0.221	CbGeAlD
Ethinyl Estradiol—CYP2C8—Etoposide—testicular cancer	0.00814	0.0265	CbGbCtD
Ethinyl Estradiol—CYP2B6—Doxorubicin—testicular cancer	0.00733	0.0239	CbGbCtD
Ethinyl Estradiol—CYP3A4—Ifosfamide—testicular cancer	0.00691	0.0225	CbGbCtD
Ethinyl Estradiol—ABCB1—Vinblastine—testicular cancer	0.00611	0.0199	CbGbCtD
Ethinyl Estradiol—ABCB1—Cisplatin—testicular cancer	0.00561	0.0183	CbGbCtD
Ethinyl Estradiol—ABCB1—Etoposide—testicular cancer	0.00551	0.018	CbGbCtD
Ethinyl Estradiol—SHBG—semen—testicular cancer	0.00458	0.122	CbGeAlD
Ethinyl Estradiol—ABCB1—Doxorubicin—testicular cancer	0.00376	0.0123	CbGbCtD
Ethinyl Estradiol—CYP3A4—Vinblastine—testicular cancer	0.00366	0.0119	CbGbCtD
Ethinyl Estradiol—ABCB1—Methotrexate—testicular cancer	0.00364	0.0119	CbGbCtD
Ethinyl Estradiol—CYP3A4—Etoposide—testicular cancer	0.0033	0.0108	CbGbCtD
Ethinyl Estradiol—CYP3A4—Doxorubicin—testicular cancer	0.00225	0.00734	CbGbCtD
Ethinyl Estradiol—SLC10A1—seminal vesicle—testicular cancer	0.00149	0.0398	CbGeAlD
Ethinyl Estradiol—SLC10A1—gonad—testicular cancer	0.00108	0.0288	CbGeAlD
Ethinyl Estradiol—AOX1—seminal vesicle—testicular cancer	0.000961	0.0256	CbGeAlD
Ethinyl Estradiol—SLC10A1—testis—testicular cancer	0.000778	0.0207	CbGeAlD
Ethinyl Estradiol—ABCB11—testis—testicular cancer	0.000769	0.0205	CbGeAlD
Ethinyl Estradiol—ESR1—embryo—testicular cancer	0.000728	0.0194	CbGeAlD
Ethinyl Estradiol—ESR2—gonad—testicular cancer	0.000721	0.0192	CbGeAlD
Ethinyl Estradiol—SHBG—gonad—testicular cancer	0.000701	0.0187	CbGeAlD
Ethinyl Estradiol—AOX1—gonad—testicular cancer	0.000694	0.0185	CbGeAlD
Ethinyl Estradiol—ESR2—female gonad—testicular cancer	0.000586	0.0156	CbGeAlD
Ethinyl Estradiol—SHBG—female gonad—testicular cancer	0.00057	0.0152	CbGeAlD
Ethinyl Estradiol—AOX1—female gonad—testicular cancer	0.000564	0.015	CbGeAlD
Ethinyl Estradiol—ESR2—testis—testicular cancer	0.00052	0.0138	CbGeAlD
Ethinyl Estradiol—SHBG—testis—testicular cancer	0.000505	0.0135	CbGeAlD
Ethinyl Estradiol—AOX1—testis—testicular cancer	0.0005	0.0133	CbGeAlD
Ethinyl Estradiol—ESR1—gonad—testicular cancer	0.000494	0.0132	CbGeAlD
Ethinyl Estradiol—ESR1—female gonad—testicular cancer	0.000401	0.0107	CbGeAlD
Ethinyl Estradiol—ABCC2—testis—testicular cancer	0.000391	0.0104	CbGeAlD
Ethinyl Estradiol—ESR2—lymph node—testicular cancer	0.000377	0.01	CbGeAlD
Ethinyl Estradiol—CYP2B6—gonad—testicular cancer	0.000365	0.00972	CbGeAlD
Ethinyl Estradiol—AOX1—lymph node—testicular cancer	0.000363	0.00966	CbGeAlD
Ethinyl Estradiol—ESR1—testis—testicular cancer	0.000356	0.00948	CbGeAlD
Ethinyl Estradiol—CYP2C8—testis—testicular cancer	0.000293	0.00781	CbGeAlD
Ethinyl Estradiol—ABCB1—embryo—testicular cancer	0.000287	0.00766	CbGeAlD
Ethinyl Estradiol—ABCC2—lymph node—testicular cancer	0.000283	0.00755	CbGeAlD
Ethinyl Estradiol—ABCB1—seminal vesicle—testicular cancer	0.00027	0.00719	CbGeAlD
Ethinyl Estradiol—CYP2B6—testis—testicular cancer	0.000263	0.00701	CbGeAlD
Ethinyl Estradiol—ESR1—lymph node—testicular cancer	0.000258	0.00687	CbGeAlD
Ethinyl Estradiol—ABCB1—gonad—testicular cancer	0.000195	0.0052	CbGeAlD
Ethinyl Estradiol—ABCB1—female gonad—testicular cancer	0.000159	0.00422	CbGeAlD
Ethinyl Estradiol—ABCB1—testis—testicular cancer	0.000141	0.00375	CbGeAlD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000103	0.00187	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000103	0.00186	CcSEcCtD
Ethinyl Estradiol—Hot flush—Doxorubicin—testicular cancer	0.000102	0.00186	CcSEcCtD
Ethinyl Estradiol—Discomfort—Cisplatin—testicular cancer	0.000102	0.00186	CcSEcCtD
Ethinyl Estradiol—Increased appetite—Doxorubicin—testicular cancer	0.000102	0.00185	CcSEcCtD
Ethinyl Estradiol—Affect lability—Epirubicin—testicular cancer	0.000102	0.00185	CcSEcCtD
Ethinyl Estradiol—Migraine—Epirubicin—testicular cancer	0.000102	0.00185	CcSEcCtD
Ethinyl Estradiol—ABCB1—lymph node—testicular cancer	0.000102	0.00272	CbGeAlD
Ethinyl Estradiol—Menopausal symptoms—Doxorubicin—testicular cancer	0.000102	0.00185	CcSEcCtD
Ethinyl Estradiol—Vomiting—Vinblastine—testicular cancer	0.000101	0.00184	CcSEcCtD
Ethinyl Estradiol—Malaise—Etoposide—testicular cancer	0.0001	0.00182	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Methotrexate—testicular cancer	0.0001	0.00182	CcSEcCtD
Ethinyl Estradiol—Headache—Vinblastine—testicular cancer	9.98e-05	0.00181	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Ifosfamide—testicular cancer	9.93e-05	0.0018	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Dactinomycin—testicular cancer	9.92e-05	0.0018	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Dactinomycin—testicular cancer	9.92e-05	0.0018	CcSEcCtD
Ethinyl Estradiol—Fatigue—Ifosfamide—testicular cancer	9.91e-05	0.0018	CcSEcCtD
Ethinyl Estradiol—Oedema—Cisplatin—testicular cancer	9.91e-05	0.0018	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Bleomycin—testicular cancer	9.91e-05	0.0018	CcSEcCtD
Ethinyl Estradiol—Infection—Cisplatin—testicular cancer	9.85e-05	0.00179	CcSEcCtD
Ethinyl Estradiol—Constipation—Ifosfamide—testicular cancer	9.83e-05	0.00179	CcSEcCtD
Ethinyl Estradiol—Mood swings—Epirubicin—testicular cancer	9.81e-05	0.00178	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Doxorubicin—testicular cancer	9.78e-05	0.00178	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Cisplatin—testicular cancer	9.72e-05	0.00177	CcSEcCtD
Ethinyl Estradiol—Cough—Etoposide—testicular cancer	9.71e-05	0.00176	CcSEcCtD
Ethinyl Estradiol—Asthenia—Bleomycin—testicular cancer	9.65e-05	0.00175	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Cisplatin—testicular cancer	9.63e-05	0.00175	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Doxorubicin—testicular cancer	9.58e-05	0.00174	CcSEcCtD
Ethinyl Estradiol—Pruritus—Bleomycin—testicular cancer	9.52e-05	0.00173	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Ifosfamide—testicular cancer	9.47e-05	0.00172	CcSEcCtD
Ethinyl Estradiol—Nausea—Vinblastine—testicular cancer	9.46e-05	0.00172	CcSEcCtD
Ethinyl Estradiol—Affect lability—Doxorubicin—testicular cancer	9.43e-05	0.00171	CcSEcCtD
Ethinyl Estradiol—Migraine—Doxorubicin—testicular cancer	9.43e-05	0.00171	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	9.41e-05	0.00171	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Ifosfamide—testicular cancer	9.4e-05	0.00171	CcSEcCtD
Ethinyl Estradiol—Discomfort—Etoposide—testicular cancer	9.36e-05	0.0017	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Epirubicin—testicular cancer	9.36e-05	0.0017	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Dactinomycin—testicular cancer	9.24e-05	0.00168	CcSEcCtD
Ethinyl Estradiol—Urticaria—Ifosfamide—testicular cancer	9.13e-05	0.00166	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Ifosfamide—testicular cancer	9.09e-05	0.00165	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Ifosfamide—testicular cancer	9.09e-05	0.00165	CcSEcCtD
Ethinyl Estradiol—Mood swings—Doxorubicin—testicular cancer	9.08e-05	0.00165	CcSEcCtD
Ethinyl Estradiol—Infection—Etoposide—testicular cancer	9.02e-05	0.00164	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Epirubicin—testicular cancer	9.01e-05	0.00164	CcSEcCtD
Ethinyl Estradiol—Asthenia—Dactinomycin—testicular cancer	9e-05	0.00164	CcSEcCtD
Ethinyl Estradiol—Dysuria—Methotrexate—testicular cancer	8.94e-05	0.00163	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Methotrexate—testicular cancer	8.89e-05	0.00162	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Etoposide—testicular cancer	8.82e-05	0.0016	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Doxorubicin—testicular cancer	8.66e-05	0.00157	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Epirubicin—testicular cancer	8.61e-05	0.00156	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Dactinomycin—testicular cancer	8.58e-05	0.00156	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Cisplatin—testicular cancer	8.56e-05	0.00156	CcSEcCtD
Ethinyl Estradiol—Vomiting—Bleomycin—testicular cancer	8.55e-05	0.00155	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Methotrexate—testicular cancer	8.53e-05	0.00155	CcSEcCtD
Ethinyl Estradiol—Infestation—Methotrexate—testicular cancer	8.53e-05	0.00155	CcSEcCtD
Ethinyl Estradiol—Depression—Methotrexate—testicular cancer	8.5e-05	0.00155	CcSEcCtD
Ethinyl Estradiol—Rash—Bleomycin—testicular cancer	8.48e-05	0.00154	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Bleomycin—testicular cancer	8.47e-05	0.00154	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Ifosfamide—testicular cancer	8.47e-05	0.00154	CcSEcCtD
Ethinyl Estradiol—Dysuria—Epirubicin—testicular cancer	8.37e-05	0.00152	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Doxorubicin—testicular cancer	8.34e-05	0.00152	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Epirubicin—testicular cancer	8.32e-05	0.00151	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Epirubicin—testicular cancer	8.27e-05	0.0015	CcSEcCtD
Ethinyl Estradiol—Asthenia—Ifosfamide—testicular cancer	8.25e-05	0.0015	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Cisplatin—testicular cancer	8.17e-05	0.00148	CcSEcCtD
Ethinyl Estradiol—Weight increased—Epirubicin—testicular cancer	8.15e-05	0.00148	CcSEcCtD
Ethinyl Estradiol—Pruritus—Ifosfamide—testicular cancer	8.13e-05	0.00148	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Epirubicin—testicular cancer	8.1e-05	0.00147	CcSEcCtD
Ethinyl Estradiol—Nausea—Bleomycin—testicular cancer	7.99e-05	0.00145	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Epirubicin—testicular cancer	7.98e-05	0.00145	CcSEcCtD
Ethinyl Estradiol—Infestation—Epirubicin—testicular cancer	7.98e-05	0.00145	CcSEcCtD
Ethinyl Estradiol—Vomiting—Dactinomycin—testicular cancer	7.98e-05	0.00145	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Doxorubicin—testicular cancer	7.97e-05	0.00145	CcSEcCtD
Ethinyl Estradiol—Rash—Dactinomycin—testicular cancer	7.91e-05	0.00144	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Ifosfamide—testicular cancer	7.87e-05	0.00143	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Etoposide—testicular cancer	7.84e-05	0.00142	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Cisplatin—testicular cancer	7.84e-05	0.00142	CcSEcCtD
Ethinyl Estradiol—Fatigue—Etoposide—testicular cancer	7.83e-05	0.00142	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Epirubicin—testicular cancer	7.82e-05	0.00142	CcSEcCtD
Ethinyl Estradiol—Constipation—Etoposide—testicular cancer	7.77e-05	0.00141	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Epirubicin—testicular cancer	7.76e-05	0.00141	CcSEcCtD
Ethinyl Estradiol—Dysuria—Doxorubicin—testicular cancer	7.74e-05	0.00141	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Doxorubicin—testicular cancer	7.7e-05	0.0014	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Methotrexate—testicular cancer	7.69e-05	0.0014	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Methotrexate—testicular cancer	7.66e-05	0.00139	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Doxorubicin—testicular cancer	7.65e-05	0.00139	CcSEcCtD
Ethinyl Estradiol—Dizziness—Ifosfamide—testicular cancer	7.6e-05	0.00138	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Methotrexate—testicular cancer	7.6e-05	0.00138	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Methotrexate—testicular cancer	7.56e-05	0.00137	CcSEcCtD
Ethinyl Estradiol—Weight increased—Doxorubicin—testicular cancer	7.54e-05	0.00137	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Methotrexate—testicular cancer	7.5e-05	0.00136	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Doxorubicin—testicular cancer	7.49e-05	0.00136	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Epirubicin—testicular cancer	7.49e-05	0.00136	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Etoposide—testicular cancer	7.48e-05	0.00136	CcSEcCtD
Ethinyl Estradiol—Nausea—Dactinomycin—testicular cancer	7.45e-05	0.00135	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Etoposide—testicular cancer	7.43e-05	0.00135	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Doxorubicin—testicular cancer	7.38e-05	0.00134	CcSEcCtD
Ethinyl Estradiol—Infestation—Doxorubicin—testicular cancer	7.38e-05	0.00134	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Methotrexate—testicular cancer	7.38e-05	0.00134	CcSEcCtD
Ethinyl Estradiol—Vomiting—Ifosfamide—testicular cancer	7.31e-05	0.00133	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Cisplatin—testicular cancer	7.3e-05	0.00133	CcSEcCtD
Ethinyl Estradiol—Rash—Ifosfamide—testicular cancer	7.25e-05	0.00132	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Ifosfamide—testicular cancer	7.24e-05	0.00132	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Methotrexate—testicular cancer	7.24e-05	0.00132	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Doxorubicin—testicular cancer	7.24e-05	0.00132	CcSEcCtD
Ethinyl Estradiol—Urticaria—Etoposide—testicular cancer	7.21e-05	0.00131	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Epirubicin—testicular cancer	7.2e-05	0.00131	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Epirubicin—testicular cancer	7.18e-05	0.00131	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Etoposide—testicular cancer	7.18e-05	0.0013	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Etoposide—testicular cancer	7.18e-05	0.0013	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Doxorubicin—testicular cancer	7.18e-05	0.0013	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Epirubicin—testicular cancer	7.16e-05	0.0013	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Methotrexate—testicular cancer	7.15e-05	0.0013	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Epirubicin—testicular cancer	7.13e-05	0.0013	CcSEcCtD
Ethinyl Estradiol—Asthenia—Cisplatin—testicular cancer	7.11e-05	0.00129	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Epirubicin—testicular cancer	7.11e-05	0.00129	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Epirubicin—testicular cancer	7.08e-05	0.00129	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Epirubicin—testicular cancer	7.04e-05	0.00128	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Epirubicin—testicular cancer	7.02e-05	0.00128	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Methotrexate—testicular cancer	6.95e-05	0.00126	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Doxorubicin—testicular cancer	6.93e-05	0.00126	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Methotrexate—testicular cancer	6.92e-05	0.00126	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Epirubicin—testicular cancer	6.9e-05	0.00125	CcSEcCtD
Ethinyl Estradiol—Nausea—Ifosfamide—testicular cancer	6.83e-05	0.00124	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Cisplatin—testicular cancer	6.78e-05	0.00123	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Epirubicin—testicular cancer	6.77e-05	0.00123	CcSEcCtD
Ethinyl Estradiol—Alopecia—Methotrexate—testicular cancer	6.77e-05	0.00123	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Methotrexate—testicular cancer	6.71e-05	0.00122	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Epirubicin—testicular cancer	6.7e-05	0.00122	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Etoposide—testicular cancer	6.69e-05	0.00122	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Methotrexate—testicular cancer	6.66e-05	0.00121	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Doxorubicin—testicular cancer	6.66e-05	0.00121	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Doxorubicin—testicular cancer	6.65e-05	0.00121	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Doxorubicin—testicular cancer	6.63e-05	0.0012	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Doxorubicin—testicular cancer	6.6e-05	0.0012	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Doxorubicin—testicular cancer	6.58e-05	0.0012	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Doxorubicin—testicular cancer	6.55e-05	0.00119	CcSEcCtD
Ethinyl Estradiol—Asthenia—Etoposide—testicular cancer	6.52e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Doxorubicin—testicular cancer	6.51e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Epirubicin—testicular cancer	6.5e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Doxorubicin—testicular cancer	6.5e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Epirubicin—testicular cancer	6.47e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Back pain—Methotrexate—testicular cancer	6.45e-05	0.00117	CcSEcCtD
Ethinyl Estradiol—Pruritus—Etoposide—testicular cancer	6.42e-05	0.00117	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Doxorubicin—testicular cancer	6.39e-05	0.00116	CcSEcCtD
Ethinyl Estradiol—Alopecia—Epirubicin—testicular cancer	6.33e-05	0.00115	CcSEcCtD
Ethinyl Estradiol—Vomiting—Cisplatin—testicular cancer	6.3e-05	0.00115	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Epirubicin—testicular cancer	6.28e-05	0.00114	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Doxorubicin—testicular cancer	6.27e-05	0.00114	CcSEcCtD
Ethinyl Estradiol—Rash—Cisplatin—testicular cancer	6.25e-05	0.00114	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Cisplatin—testicular cancer	6.24e-05	0.00113	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Epirubicin—testicular cancer	6.24e-05	0.00113	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Etoposide—testicular cancer	6.21e-05	0.00113	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Doxorubicin—testicular cancer	6.2e-05	0.00113	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Methotrexate—testicular cancer	6.18e-05	0.00112	CcSEcCtD
Ethinyl Estradiol—Back pain—Epirubicin—testicular cancer	6.03e-05	0.0011	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Doxorubicin—testicular cancer	6.01e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Malaise—Methotrexate—testicular cancer	6.01e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Dizziness—Etoposide—testicular cancer	6e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Epirubicin—testicular cancer	6e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Doxorubicin—testicular cancer	5.99e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Nausea—Cisplatin—testicular cancer	5.89e-05	0.00107	CcSEcCtD
Ethinyl Estradiol—Alopecia—Doxorubicin—testicular cancer	5.86e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Cough—Methotrexate—testicular cancer	5.82e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Doxorubicin—testicular cancer	5.81e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Epirubicin—testicular cancer	5.79e-05	0.00105	CcSEcCtD
Ethinyl Estradiol—Vomiting—Etoposide—testicular cancer	5.77e-05	0.00105	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Doxorubicin—testicular cancer	5.77e-05	0.00105	CcSEcCtD
Ethinyl Estradiol—Rash—Etoposide—testicular cancer	5.73e-05	0.00104	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Etoposide—testicular cancer	5.72e-05	0.00104	CcSEcCtD
Ethinyl Estradiol—Headache—Etoposide—testicular cancer	5.69e-05	0.00103	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	5.63e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Malaise—Epirubicin—testicular cancer	5.62e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Discomfort—Methotrexate—testicular cancer	5.61e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Back pain—Doxorubicin—testicular cancer	5.58e-05	0.00101	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Doxorubicin—testicular cancer	5.55e-05	0.00101	CcSEcCtD
Ethinyl Estradiol—Cough—Epirubicin—testicular cancer	5.44e-05	0.000989	CcSEcCtD
Ethinyl Estradiol—Infection—Methotrexate—testicular cancer	5.4e-05	0.000982	CcSEcCtD
Ethinyl Estradiol—Nausea—Etoposide—testicular cancer	5.39e-05	0.00098	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Doxorubicin—testicular cancer	5.35e-05	0.000973	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Methotrexate—testicular cancer	5.33e-05	0.000969	CcSEcCtD
Ethinyl Estradiol—Anxiety—Epirubicin—testicular cancer	5.29e-05	0.000962	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Methotrexate—testicular cancer	5.28e-05	0.00096	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	5.27e-05	0.000958	CcSEcCtD
Ethinyl Estradiol—Discomfort—Epirubicin—testicular cancer	5.25e-05	0.000953	CcSEcCtD
Ethinyl Estradiol—Malaise—Doxorubicin—testicular cancer	5.2e-05	0.000946	CcSEcCtD
Ethinyl Estradiol—Oedema—Epirubicin—testicular cancer	5.09e-05	0.000925	CcSEcCtD
Ethinyl Estradiol—Infection—Epirubicin—testicular cancer	5.06e-05	0.000919	CcSEcCtD
Ethinyl Estradiol—Cough—Doxorubicin—testicular cancer	5.04e-05	0.000915	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Epirubicin—testicular cancer	4.99e-05	0.000907	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Epirubicin—testicular cancer	4.94e-05	0.000898	CcSEcCtD
Ethinyl Estradiol—Anxiety—Doxorubicin—testicular cancer	4.9e-05	0.00089	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	4.88e-05	0.000887	CcSEcCtD
Ethinyl Estradiol—Discomfort—Doxorubicin—testicular cancer	4.85e-05	0.000882	CcSEcCtD
Ethinyl Estradiol—Oedema—Doxorubicin—testicular cancer	4.71e-05	0.000856	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Methotrexate—testicular cancer	4.7e-05	0.000853	CcSEcCtD
Ethinyl Estradiol—Fatigue—Methotrexate—testicular cancer	4.69e-05	0.000852	CcSEcCtD
Ethinyl Estradiol—Infection—Doxorubicin—testicular cancer	4.68e-05	0.00085	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Doxorubicin—testicular cancer	4.62e-05	0.000839	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Doxorubicin—testicular cancer	4.57e-05	0.000831	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Methotrexate—testicular cancer	4.48e-05	0.000814	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Methotrexate—testicular cancer	4.45e-05	0.000808	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Epirubicin—testicular cancer	4.39e-05	0.000799	CcSEcCtD
Ethinyl Estradiol—Fatigue—Epirubicin—testicular cancer	4.39e-05	0.000797	CcSEcCtD
Ethinyl Estradiol—Constipation—Epirubicin—testicular cancer	4.35e-05	0.000791	CcSEcCtD
Ethinyl Estradiol—Urticaria—Methotrexate—testicular cancer	4.32e-05	0.000785	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Methotrexate—testicular cancer	4.3e-05	0.000781	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Methotrexate—testicular cancer	4.3e-05	0.000781	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Epirubicin—testicular cancer	4.19e-05	0.000762	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Epirubicin—testicular cancer	4.16e-05	0.000756	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Doxorubicin—testicular cancer	4.07e-05	0.000739	CcSEcCtD
Ethinyl Estradiol—Fatigue—Doxorubicin—testicular cancer	4.06e-05	0.000738	CcSEcCtD
Ethinyl Estradiol—Urticaria—Epirubicin—testicular cancer	4.04e-05	0.000735	CcSEcCtD
Ethinyl Estradiol—Constipation—Doxorubicin—testicular cancer	4.03e-05	0.000732	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Epirubicin—testicular cancer	4.02e-05	0.000731	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Epirubicin—testicular cancer	4.02e-05	0.000731	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Methotrexate—testicular cancer	4.01e-05	0.000728	CcSEcCtD
Ethinyl Estradiol—Asthenia—Methotrexate—testicular cancer	3.9e-05	0.000709	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Doxorubicin—testicular cancer	3.88e-05	0.000705	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Doxorubicin—testicular cancer	3.85e-05	0.0007	CcSEcCtD
Ethinyl Estradiol—Pruritus—Methotrexate—testicular cancer	3.85e-05	0.000699	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Epirubicin—testicular cancer	3.75e-05	0.000681	CcSEcCtD
Ethinyl Estradiol—Urticaria—Doxorubicin—testicular cancer	3.74e-05	0.00068	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Doxorubicin—testicular cancer	3.72e-05	0.000677	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Doxorubicin—testicular cancer	3.72e-05	0.000677	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Methotrexate—testicular cancer	3.72e-05	0.000676	CcSEcCtD
Ethinyl Estradiol—Asthenia—Epirubicin—testicular cancer	3.65e-05	0.000664	CcSEcCtD
Ethinyl Estradiol—Pruritus—Epirubicin—testicular cancer	3.6e-05	0.000654	CcSEcCtD
Ethinyl Estradiol—Dizziness—Methotrexate—testicular cancer	3.6e-05	0.000654	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Epirubicin—testicular cancer	3.48e-05	0.000633	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Doxorubicin—testicular cancer	3.47e-05	0.000631	CcSEcCtD
Ethinyl Estradiol—Vomiting—Methotrexate—testicular cancer	3.46e-05	0.000628	CcSEcCtD
Ethinyl Estradiol—Rash—Methotrexate—testicular cancer	3.43e-05	0.000623	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Methotrexate—testicular cancer	3.43e-05	0.000623	CcSEcCtD
Ethinyl Estradiol—Headache—Methotrexate—testicular cancer	3.41e-05	0.000619	CcSEcCtD
Ethinyl Estradiol—Asthenia—Doxorubicin—testicular cancer	3.38e-05	0.000614	CcSEcCtD
Ethinyl Estradiol—Dizziness—Epirubicin—testicular cancer	3.37e-05	0.000612	CcSEcCtD
Ethinyl Estradiol—Pruritus—Doxorubicin—testicular cancer	3.33e-05	0.000606	CcSEcCtD
Ethinyl Estradiol—Vomiting—Epirubicin—testicular cancer	3.24e-05	0.000588	CcSEcCtD
Ethinyl Estradiol—Nausea—Methotrexate—testicular cancer	3.23e-05	0.000587	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Doxorubicin—testicular cancer	3.22e-05	0.000586	CcSEcCtD
Ethinyl Estradiol—Rash—Epirubicin—testicular cancer	3.21e-05	0.000583	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Epirubicin—testicular cancer	3.21e-05	0.000583	CcSEcCtD
Ethinyl Estradiol—Headache—Epirubicin—testicular cancer	3.19e-05	0.000579	CcSEcCtD
Ethinyl Estradiol—Dizziness—Doxorubicin—testicular cancer	3.11e-05	0.000566	CcSEcCtD
Ethinyl Estradiol—Nausea—Epirubicin—testicular cancer	3.02e-05	0.000549	CcSEcCtD
Ethinyl Estradiol—Vomiting—Doxorubicin—testicular cancer	2.99e-05	0.000544	CcSEcCtD
Ethinyl Estradiol—Rash—Doxorubicin—testicular cancer	2.97e-05	0.00054	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Doxorubicin—testicular cancer	2.97e-05	0.000539	CcSEcCtD
Ethinyl Estradiol—Headache—Doxorubicin—testicular cancer	2.95e-05	0.000536	CcSEcCtD
Ethinyl Estradiol—Nausea—Doxorubicin—testicular cancer	2.8e-05	0.000508	CcSEcCtD
